Relevant bibliographies by topics / Tumour associated carbohydrate

Academic literature on the topic 'Tumour associated carbohydrate'

Author: Grafiati
Published: 10 December 2022
Last updated: 28 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Tumour associated carbohydrate.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Tumour associated carbohydrate"

1

Toyokuni, Tatsushi, and Anil K. Singhal. "Synthetic carbohydrate vaccines based on tumour-associated antigens." Chemical Society Reviews 24, no. 4 (1995): 231. http://dx.doi.org/10.1039/cs9952400231.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

TOYOKUNI, T., and A. K. SINGHAL. "ChemInform Abstract: Synthetic Carbohydrate Vaccines Based on Tumour-Associated Antigens." ChemInform 27, no. 6 (August 12, 2010): no. http://dx.doi.org/10.1002/chin.199606316.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Pinczower, Gideon D., Roderick P. W. Williams, Robert D. Gianello, H. Clem Robinson, Barry N. Preston, and Anthony W. Linnane. "Characterisation of the tumour-associated carbohydrate epitope recognised by monoclonal antibody 4D3." International Journal of Cancer 66, no. 5 (May 29, 1996): 636–44. http://dx.doi.org/10.1002/(sici)1097-0215(19960529)66:5<636::aid-ijc10>3.0.co;2-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hounsell, Elizabeth F., MIA Young, and Michael J. Davies. "Glycoprotein Changes in Tumours: A Renaissance in Clinical Applications." Clinical Science 93, no. 4 (October 1, 1997): 287–93. http://dx.doi.org/10.1042/cs0930287.

Full text
Abstract:
1. Oligosaccharides linked to protein (glycoprotein) or lipid (glycolipid) are the major components at the outer surface of mammalian cells. Studies using antibodies and lectins have shown in the past that the oligosaccharides they recognize exhibit tumour-associated changes, i.e. they are carbohydrate tumour-associated antigens. 2. The oligosaccharides have been further characterized in recent years by structural analysis using high-resolution chromatographic techniques, MS and NMR. NMR gives an oligosaccharide fingerprint that is characteristic of monosaccharide type and linkage and which can be correlated with magnetic resonance spectroscopic data on fine-needle tissue aspirates. 3. Also of relevance is the new understanding of the molecular biology of MUC genes, which code for mucin protein backbones, and of the glycosyltransferase genes, which determine oligosaccharide structure and immunological recognition. 4. For these reasons, we believe that tumour-associated oligosaccharide changes should be revisited in the context of what we now know about structure and expression. This review synopsizes the past data using the detection of carbohydrate tumour-associated antigens by binding of lectins and antibodies, and puts it into the context of NMR fingerprints or signatures.
APA, Harvard, Vancouver, ISO, and other styles
5

PUTZ, E. F., and D. N. MANNEL. "Monocyte Activation by Tumour Cells: a Role for Carbohydrate Structures Associated with CD2." Scandinavian Journal of Immunology 41, no. 1 (January 1995): 77–84. http://dx.doi.org/10.1111/j.1365-3083.1995.tb03536.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Franco, A. "CTL-Based Cancer Preventive/Therapeutic Vaccines for Carcinomas: Role of Tumour-Associated Carbohydrate Antigens." Scandinavian Journal of Immunology 61, no. 5 (May 2005): 391–97. http://dx.doi.org/10.1111/j.1365-3083.2005.01596.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Nativi, Cristina, Francesco Papi, and Stefano Roelens. "Tn antigen analogues: the synthetic way to “upgrade” an attracting tumour associated carbohydrate antigen (TACA)." Chemical Communications 55, no. 54 (2019): 7729–36. http://dx.doi.org/10.1039/c9cc02920f.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

da Costa, Valeria, and Teresa Freire. "Advances in the Immunomodulatory Properties of Glycoantigens in Cancer." Cancers 14, no. 8 (April 7, 2022): 1854. http://dx.doi.org/10.3390/cancers14081854.

Full text
Abstract:
Aberrant glycosylation in tumour progression is currently a topic of main interest. Tumour-associated carbohydrate antigens (TACAs) are expressed in a wide variety of epithelial cancers, being both a diagnostic tool and a potential treatment target, as they have impact on patient outcome and disease progression. Glycans affect both tumour-cell biology properties as well as the antitumor immune response. It has been ascertained that TACAs affect cell migration, invasion and metastatic properties both when expressed by cancer cells or by their extracellular vesicles. On the other hand, tumour-associated glycans recognized by C-type lectin receptors in immune cells possess immunomodulatory properties which enable tumour growth and immune response evasion. Yet, much remains unknown, concerning mechanisms involved in deregulation of glycan synthesis and how this affects cell biology on a major level. This review summarises the main findings to date concerning how aberrant glycans influence tumour growth and immunity, their application in cancer treatment and spotlights of unanswered challenges remaining to be solved.
APA, Harvard, Vancouver, ISO, and other styles
9

Saeland, Eirikur, and Yvette van Kooyk. "Highly glycosylated tumour antigens: interactions with the immune system." Biochemical Society Transactions 39, no. 1 (January 19, 2011): 388–92. http://dx.doi.org/10.1042/bst0390388.

Full text
Abstract:
A common phenotypic change in cancer is a dramatic transformation of cellular glycosylation. Functional studies of particular tumour-associated oligosaccharides are difficult to interpret conclusively, but carbohydrate-binding proteins are likely to contribute to progression of the tumour. This review discusses the potential role of CLRs (C-type lectin receptors), expressed by antigen-presenting cells of the immune system, in tumour recognition and immune modulation. Studies in recent years have provided significant insight into the immunomodulatory function of CLR during infections, but their role in cancer remains elusive; some strongly bind tumour cells and antigens, indicating participation in malignancy. The potential to use recombinant CLR as diagnostic tools will also be discussed.
APA, Harvard, Vancouver, ISO, and other styles
10

Jiang, Bei-ge, Rui-liang Ge, Liang-liang Sun, Ming Zong, Gong-tian Wei, and Yong-jie Zhang. "Clinical Parameters Predicting Survival Duration after Hepatectomy for Intrahepatic Cholangiocarcinoma." Canadian Journal of Gastroenterology 25, no. 11 (2011): 603–8. http://dx.doi.org/10.1155/2011/917097.

Full text
Abstract:
BACKGROUND: Currently, the most effective treatment for intrahepatic cholangiocarcinoma (ICC) is complete hepatic tumour excision.OBJECTIVE: To identify the clinical parameters associated with survival duration for ICC patients following hepatectomy, and to construct a mathematical model for predicting survival duration.METHODS: Demographic data and clinical variables for 102 patients diagnosed with ICC, who underwent exploratory laparotomy at a single centre from July 1998 to December 2000 and were followed for an average of 24 months, were collected in 2011. Patients were randomly assigned into training (n=76) and validation (n=26) groups. Univariate and multivariate analyses were performed to identify factors associated with posthepatectomy survival duration.RESULTS: Univariate analysis revealed that more than three lymph node metastases, a serum carbohydrate antigen 19-9 level >37 U/mL, stage IVa tumours, and intra- or perihepatic metastases were significantly associated with decreased survival duration. Curative resection was significantly associated with increased survival duration. A mathematical model incorporating parameters of age, sex, metastatic lymph node number, curative surgery, carbohydrate antigen 19-9 concentration, alpha-fetoprotein concentration, hepatitis B, TNM stage and tumour differentiation was constructed for predicting survival duration. For a survival duration of less than one year, the model exhibited 93.8% sensitivity, 92.3% total accuracy and a positive predictive value of 93.8%; for a survival duration of one to three years, the corresponding values were 80.0%, 69.2% and 57.1%, repsectively.CONCLUSIONS: The mathematical model presented in the current report should prove to be useful in the clinical setting for predicting the extent to which curative resection affects the survival of ICC patients, and for selecting optimal postoperative treatment strategies.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Tumour associated carbohydrate"

1

Youakim, Adel. "Tumour- and differentiation-associated changes in the carbohydrate structure of glycoproteins from human colonic cells." Thesis, McGill University, 1988. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=75826.

Full text
Abstract:
The structure of the carbohydrate associated with glycoproteins was examined in various human colonic tumour cells in culture following incubation with labeled sugars. Glycopeptides obtained by pronase digestion of the cell surface glycoproteins of three human colon tumours (HCT-8R, CaCo-2, and HCT-15) were compared with those from cells (CCL 239) derived normal adult colon. The tumour cells contain large molecular weight fucose-labeled glycopeptides that are absent in the CCL 239 cells. The large molecular weight fucose- and glucosamine-labeled glycopeptides from HCT-8R cells contain mainly mild alkali labile O-linked oligosaccharides, whereas those isolated from CaCo-2 cells contain primarily N-linked polylactosaminoglycans which bind to Datura stramonium agglutinin-agarose and are sensitive to endo-$ beta$-galactosidase.
Differentiation of CaCo-2 cells to polarized cells containing brush border enzymes characteristic of enterocytes is accompanied by a decrease in the relative proportion of fucose- and glucosamine-labeled N-linked polylactosaminoglycans-containing glycopeptides. These polylactosaminoglycans are found on a restricted set of glycoproteins of M$ sb{ rm r}$ 100,000-130,000. In undifferentiated cells, these glycoproteins contain a greater proportion of polylactosaminoglycans than those from differentiated cells.
APA, Harvard, Vancouver, ISO, and other styles
2

Shi, Mengchao. "Design and Synthesis of a Novel Entirely Carbohydrate-Based Conjugate for Cancer Vaccine Development." University of Toledo / OhioLINK, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=toledo1470412718.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kleski, Kristopher A. "Progress of Entirely Carbohydrate Conjugates in Cancer Immunotherapeutics – Syntheses and Developments." University of Toledo / OhioLINK, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=toledo1586980386810219.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Trabbic, Kevin R. "Approaches to Increase the Immunogenicity of Carbohydrate Antigens Using PS A1 and Subsequent Immunotherapies." University of Toledo / OhioLINK, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=toledo1470330973.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Yamazaki, Yuji. "Investigation on Chemical and Enzymatic Synthesis of Tumor Associated Carbohydrate Antigens Triggering Immune Responses." Kyoto University, 2019. http://hdl.handle.net/2433/242472.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Zou, Jun. "Characterization of peptides and phage that bind galectin-3 selected from bacteriophage display libraries a study of the role of galectin-3 in metastasis-associated cancer cell adhesion /." Diss., Columbia, Mo. : University of Missouri-Columbia, 2005. http://hdl.handle.net/10355/4149.

Full text
Abstract:
Thesis (Ph. D.)--University of Missouri-Columbia, 2005.
"December 2005" The entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Vita. Includes bibliographical references.
APA, Harvard, Vancouver, ISO, and other styles
7

LIU, SI-XIAN, and 劉思嫺. "Preparation of Carbohydrate Polymers Containing Three Different Tumor-Associated Carbohydrate Antigens." Thesis, 2019. http://ndltd.ncl.edu.tw/handle/2sgct7.

Full text
Abstract:
碩士
輔仁大學
化學系
107
Preparation of styrene-type glycoconjugates monomers, containing tumor-associated carbohydrate antigens (TACAs), such as Tn (Ser- / Thr- type), TF and sTn were developed. Polymerization of these TACAs monomers with polystyrene framework by NMP (Nitroxide-mediated radical polymerization) were also studied. Tn antigens were synthesized by the glycosylation reactions of D-galactose derivative, as glycol donor and L-serine or L-threonine derivatives as glycol acceptors. The first glycosylation reaction was proceeded to get the glycoproteins building blocks. The α-anomer was separated, and then attached to styrene through a spacer of diethylene glycol amine. The Tn glycoconjugate monomers were polymerized successfully to afford Tn glycoconjugate glycopolymers. To prepare others antigens, several functional groups were protected. Attachments of the second carbohydrate moieties, such as D-galatose and sialic acid, were constructed by the second glycosylation reactions. These two antigens were synthesized by the same methods used in the synthesis of Tn monomers, and eventually afforded three different types of glycoconjugates monomers. Controlled living radical polymerization (CLRP) of these three Tn glycoconjugate monomers were studied to produce the random and block co-polymers. Resulting glycopolymers were analyzed by NMR and ATR-IR to confirm TACAs presented on the polystyrene backbone.
APA, Harvard, Vancouver, ISO, and other styles
8

Jan, Fan-Dan, and 詹凡丹. "Synthese and Immunogenicities of Tumor-Associated Carbohydrate Vaccines." Thesis, 2009. http://ndltd.ncl.edu.tw/handle/02685009606746575616.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Huang, Yu-Ching, and 黃郁清. "Synthesis of S-Linked GD3 Tumor-Associated Carbohydrate Antigen." Thesis, 2010. http://ndltd.ncl.edu.tw/handle/92445270678667358695.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

LeClair, Christopher Arthur. "Advances towards synthesis of C-glycosyl tumor-associated carbohydrate antigens /." 2006. http://wwwlib.umi.com/dissertations/fullcit/3225946.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Tumour associated carbohydrate"

1

Chuang, Hong-Yang. Synthesis and Vaccine Evaluation of the Tumor Associated Carbohydrate Antigen RM2 from Prostate Cancer. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-46848-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Chuang, Hong-Yang. Synthesis and Vaccine Evaluation of the Tumor Associated Carbohydrate Antigen RM2 from Prostate Cancer. Springer, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Chuang, Hong-Yang. Synthesis and Vaccine Evaluation of the Tumor Associated Carbohydrate Antigen RM2 from Prostate Cancer. Springer Berlin / Heidelberg, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chuang, Hong-Yang. Synthesis and Vaccine Evaluation of the Tumor Associated Carbohydrate Antigen RM2 from Prostate Cancer. Springer, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nicholson, Grainne, and George M. Hall. Neuroendocrine physiology in anaesthetic practice. Edited by Jonathan G. Hardman. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199642045.003.0008.

Full text
Abstract:
This chapter describes the hormonal, metabolic, and inflammatory response to surgery—commonly known as the surgical stress response. The changes in protein, carbohydrate, and fat metabolism to provide fuel for oxidation are outlined as well as changes in salt and water metabolism. Psychological sequelae of fatigue and malaise are also common in patients undergoing surgery. Attenuating the metabolic and endocrine changes associated with surgery may reduce postoperative morbidity and expedite recovery; the choice of anaesthetic drugs and techniques (regional vs general anaesthesia) and the increasing use of laparoscopic surgery have all been used to try to achieve this objective. The most common metabolic disease which anaesthetists have to manage is diabetes mellitus (DM) and its pathophysiology and medical management, as well as that of the related metabolic syndrome are discussed. Adrenal tumours are rare but usually require surgical excision. Phaeochromocytomas present unique anaesthetic challenges, but pre-, intra-, and postoperatively in terms of fluid management and blood pressure control. Conn’s syndrome (primary hyperaldosteronism) can also result in hypertension and electrolyte disturbances. Cushing’s disease (glucocorticoid excess) presents with the clinical effects of steroid excess and many patients have concomitant DM. Finally, perioperative steroid supplementation for patients already taking steroids and undergoing surgery is discussed.
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Tumour associated carbohydrate"

1

Hounsell, E. F., H. C. Gooi, and T. Feizi. "Tumour-Associated Carbohydrate Antigens of Glycoproteins." In Investigation and Exploitation of Antibody Combining Sites, 317–22. Boston, MA: Springer US, 1985. http://dx.doi.org/10.1007/978-1-4684-5006-4_38.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hakomori, Sen-itiroh. "Tumor-Associated Carbohydrate Markers." In Serological Cancer Markers, 207–32. Totowa, NJ: Humana Press, 1992. http://dx.doi.org/10.1007/978-1-4612-0401-5_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Anderson, Byron, Lyman E. Davis, and Mario Venegas. "Tumor-Associated Blood Group Antigen Expressions and Immunoglobulins Associated with Tumors." In The Molecular Immunology of Complex Carbohydrates, 601–56. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-1663-3_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hakomori, Sen-itiroh. "Tumor-Associated Carbohydrate Antigens Defining Tumor Malignancy: Basis for Development of Anti-Cancer Vaccines." In The Molecular Immunology of Complex Carbohydrates —2, 369–402. Boston, MA: Springer US, 2001. http://dx.doi.org/10.1007/978-1-4615-1267-7_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hakomori, Sen-itiroh. "Histo-Blood Group Antigens as Tumor-Associated Carbohydrate Antigens and Ligands for Cell Adhesion." In Molecular Basis of Human Blood Group Antigens, 421–43. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4757-9537-0_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hirabayashi, Yoshio, Makoto Matsumoto, Hideyoshi Higashi, and Shiro Kato. "N-Glycolylneuraminic Acid-Containing Gangliosides as a Tumor Associated Antigen in Human: Expression of Hanganutziu-Deicher Antigen Active Gangliosides on Human Colon Carcinoma and Melanoma Tissues." In The Molecular Immunology of Complex Carbohydrates, 725–26. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-1663-3_30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chua, Jia Xin, and Lindy Durrant. "Monoclonal Antibodies Against Tumour-Associated Carbohydrate Antigens." In Carbohydrate. InTech, 2017. http://dx.doi.org/10.5772/66996.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

"Tumor Associated Carbohydrate Antigens." In Encyclopedia of Cancer, 3792. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_6018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hakomori, Sen-itiroh. "Aberrant Glycosylation In Tumors And Tumor-Associated Carbohydrate Antigens." In Advances in Cancer Research, 257–331. Elsevier, 1989. http://dx.doi.org/10.1016/s0065-230x(08)60215-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hakomori, Sen-itiroh. "Chapter 4 Tumor-associated carbohydrate antigens and modified blood group antigens." In New Comprehensive Biochemistry, 243–76. Elsevier, 1996. http://dx.doi.org/10.1016/s0167-7306(08)60290-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Tumour associated carbohydrate"

1

Thomas, David, Emma Bermingham, Mark Roberts, and Wayne Young. "An investigation into the effect of high fat and carbohydrate diets on a range of biomarkers associated with pancreatitis in dogs." In 2022 AOCS Annual Meeting & Expo. American Oil Chemists' Society (AOCS), 2022. http://dx.doi.org/10.21748/uvdt4784.

Full text
Abstract:
Studies suggest that dogs preferentially choose fat as their major dietary energy source (59-63% of the total metabolisable energy (ME) content of the diet). However, high fat diets have been linked to the development of pancreatitis in dogs. This study investigated several biomarkers associated with pancreatitis in dogs fed either a high fat (HF; Protein: Fat: Carbohydrate content; 35%:63%:2% ME; n= 10 dogs) or high carbohydrate (HC; Protein: Fat: Carbohydrate content; 17%:32%:51% ME) diet.A high fat meal tolerance test (MTT) was undertaken on dogs (n=20) at baseline consuming a commercial dry food diet (Protein: Fat: Carbohydrate content; 23%:25%:52% on an ME basis) and then again after 8 weeks consuming either a HF (n=10) or HC (n=10) diet. Briefly, after an overnight fast, dogs were fed a single meal containing 100% of their daily requirements (P: F: C content; 35%:63%:2% ME). Each dog was then blood sampled 1, 2, 3, 4, 5, 6, 12, and 24 hours post-prandially. Samples were analysed for plasma triglycerides and markers of pancreatitis (i.e., pancreatic lipase, endotoxin, C-reactive protein, Interleukin 1-alpha, Interleukin 6 and Tumour necrosis factor-alpha). The postprandial peak plasma concentration of triglycerides (Cmax) were higher (p less than 0.001) at baseline, compared to after feeding of the either the HC or HF diets for 8 weeks. This suggests dietary components such as moisture level, specific ingredients, level of diet processing, and possibly apparent nutrient digestibility were potential factors driving this response. There was no effect of feeding either HF or HC diets on Cmax values (P >0.05) during the final MTT. This study suggests that feeding a HF diet for 8 weeks does not elevate blood markers associated with pancreatitis, with the serum biochemistry and complete blood count indicating the dogs remained clinically healthy.
APA, Harvard, Vancouver, ISO, and other styles
2

Svarovsky, Sergei A., and Joseph J. Barchi. "SYNTHESIS OF MULTIVALENT TUMOR-ASSOCIATED GLYCOPEPTIDE ANTIGENS AS POTENTIAL CANCER VACCINES." In XXIst International Carbohydrate Symposium 2002. TheScientificWorld Ltd, 2002. http://dx.doi.org/10.1100/tsw.2002.680.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Pandey, Divya, Neha Pruthi, and Sudha Salhan. "Unusually high serum Ca 19-9 in a benign ovarian tumor." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685327.

Full text
Abstract:
Introduction: Ovarian tumors have a varied spectrum of presentation. Tumors which look malignant clinico-biochemically can ultimately turn out to be benign. Tumor markers help in diagnosing various malignancies. Carbohydrate antigen 19-9 is one such marker seen to be elevated in some ovarian tumors. Case: A 55 year old, lean and thin postmenopausal female presented to Gynae OPD with abdominal mass, anorexia and weight loss developing over last 6 months. During workup, she was found to have unusually high Ca 19-9 along with MRI findings suggestive of ovarian tumor. Staging laparotomy followed by total abdominal hysterectomy with bilateral salpingoophorectomy was performed. Per operative findings were suggestive of benign nature of ovarian tumor of size 18× 20 cm. Patient was kept under follow up. Histopathology report showed benign mucinous cystadenoma. The serum levels of Ca19-9 returned to normal 8 weeks following surgery. This case report shows a rare and significant elevation of Ca19-9 levels with benign mucinous cystadenoma of the ovary, thus showing that women with unusually elevated tumor markers and even symptoms suggesting malignancy may actually harbour a benign disease. Conclusion: Unusually high Ca 19-9 may be associated with benign mucinous cystadenoma but thorough workup to rule out malignancy is a must in every case.
APA, Harvard, Vancouver, ISO, and other styles
4

Kieber-Emmons, T., LF Hutchins, PD Emanuel, A. Pennisi, E. Siegel, F. Jousheghany, BM Karbassi, and I. Makhoul. "Abstract P6-10-06: Inducing immune responses to tumor associated carbohydrate antigens by a carbohydrate mimetic peptide vaccine: Clinical experience in phase I and phase II trials." In Abstracts: 2016 San Antonio Breast Cancer Symposium; December 6-10, 2016; San Antonio, Texas. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.sabcs16-p6-10-06.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Verret, B., C. Rossoni, D. Lebeherec, S. Michiels, E. Castanon-Alvarez, C. Leclerc, S. Delaloge, C. Artaud, and M. Lacroix-Tikri. "Abstract P3-05-14: Expression of the tumor associated carbohydrate antigen Tn and immune effectors in invasive breast cancer." In Abstracts: 2017 San Antonio Breast Cancer Symposium; December 5-9, 2017; San Antonio, Texas. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.sabcs17-p3-05-14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Dransfield, Daniel T., Jillian M. Prendergast, David A. Eavarone, Rawan Nazer, Linah Al-Alem, Jenna Stein, Jeff Behrens, and Bo Rueda. "Abstract B28: Targeting the tumor-associated carbohydrate antigen STn with humanized anti-Sialyl-Tn monoclonal antibody-drug conjugates inhibits ovarian cancer tumor growth in vitro and in vivo." In Abstracts: AACR Special Conference: Addressing Critical Questions in Ovarian Cancer Research and Treatment; October 1-4, 2017; Pittsburgh, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1557-3265.ovca17-b28.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Tumour associated carbohydrate' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography